SF3B1 and neoplasm: In fact, we demonstrate for the first time a drastic SF3B1 overexpression (at mRNA/protein levels) in different cohorts of GBMs vs. non-tumor tissues, which was also confirmed in EPed-glioma mouse models vs. control samples.